Financial Market At The Start Of An Upswing, For Companies With Focused Strategies
Great Story Not Enough; Milestones Must Be Near And Clear
Investors, advisors and companies that have raised cash recently insist funding is available and IPOs are possible for drug developers that can clearly outline future clinical milestones.
